Here are three things to know:
1. Baxter Ventures, the venture investment arm of Baxter International, led the funding round. Other investors included Summation Health, CWC HealthTech Advisors and Stanford-StartX Fund.
2. The funding will accelerate the availability of Prescient Surgical’s CleanCision therapy, which targets the sources of surgical site infection.
3. SSI, particularly in abdominal surgery, poses a significant threat to patient safety. An estimated 15 percent of patients undergoing high-risk abdominal surgery will develop an SSI.
More articles on quality:
Can electronic monitoring systems improve hand hygiene? 4 study findings
6 ways ASCs can optimize patient satisfaction
How Andrews Institute Ambulatory Surgery Center cut flash sterilization episodes from 2.4K to 0
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
